Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Human Gene Therapy
|
March 1, 1996
Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models
J A Eastham, S H Chen, I Sehgal, et al.
Cancer
|
February 1, 1993
Transgenic models for the study of prostate cancer
T C Thompson, L D Truong, T L Timme, et al.
Oncogene
|
March 2, 1995
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer
T C Thompson, S H Park, T L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter
C Pramudji, S Shimura, S Ebara, et al.
Cancer Research
|
June 5, 2001
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells
L Li, G Yang, S Ebara, et al.
Prostate Cancer and Prostatic Diseases
|
March 11, 2003
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters
S Ebara, S Shimura, Y Nasu, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1992
Transforming growth factor beta 1 as a biomarker for prostate cancer
T C Thompson, L D Truong, T L Timme, et al.
Nature Medicine
|
September 12, 1998
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells
Y Nasu, T L Timme, G Yang, et al.
Cancer Research
|
May 19, 2001
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer
S A Tahir, G Yang, S Ebara, et al.
Cancer Gene Therapy
|
March 17, 1999
Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer
S J Hall, S E Mutchnik, G Yang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Human Gene Therapy
|
March 1, 1996
Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models
J A Eastham, S H Chen, I Sehgal, et al.
Cancer
|
February 1, 1993
Transgenic models for the study of prostate cancer
T C Thompson, L D Truong, T L Timme, et al.
Oncogene
|
March 2, 1995
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer
T C Thompson, S H Park, T L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter
C Pramudji, S Shimura, S Ebara, et al.
Cancer Research
|
June 5, 2001
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells
L Li, G Yang, S Ebara, et al.
Prostate Cancer and Prostatic Diseases
|
March 11, 2003
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters
S Ebara, S Shimura, Y Nasu, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1992
Transforming growth factor beta 1 as a biomarker for prostate cancer
T C Thompson, L D Truong, T L Timme, et al.
Nature Medicine
|
September 12, 1998
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells
Y Nasu, T L Timme, G Yang, et al.
Cancer Research
|
May 19, 2001
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer
S A Tahir, G Yang, S Ebara, et al.
Cancer Gene Therapy
|
March 17, 1999
Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer
S J Hall, S E Mutchnik, G Yang, et al.
Page
of 6